rs2230919

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002872.5(RAC2):​c.252C>T​(p.Leu84Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00427 in 1,552,320 control chromosomes in the GnomAD database, including 123 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 71 hom., cov: 31)
Exomes 𝑓: 0.0027 ( 52 hom. )

Consequence

RAC2
NM_002872.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.57

Publications

1 publications found
Variant links:
Genes affected
RAC2 (HGNC:9802): (Rac family small GTPase 2) This gene encodes a member of the Ras superfamily of small guanosine triphosphate (GTP)-metabolizing proteins. The encoded protein localizes to the plasma membrane, where it regulates diverse processes, such as secretion, phagocytosis, and cell polarization. Activity of this protein is also involved in the generation of reactive oxygen species. Mutations in this gene are associated with neutrophil immunodeficiency syndrome. There is a pseudogene for this gene on chromosome 6. [provided by RefSeq, Jul 2013]
RAC2 Gene-Disease associations (from GenCC):
  • immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen
  • immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • neutrophil immunodeficiency syndrome
    Inheritance: Unknown, AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 22-37231968-G-A is Benign according to our data. Variant chr22-37231968-G-A is described in ClinVar as Benign. ClinVar VariationId is 378454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.57 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0599 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAC2NM_002872.5 linkc.252C>T p.Leu84Leu synonymous_variant Exon 4 of 7 ENST00000249071.11 NP_002863.1 P15153A0A024R1P2V9H0H7
RAC2XM_006724286.4 linkc.252C>T p.Leu84Leu synonymous_variant Exon 4 of 6 XP_006724349.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAC2ENST00000249071.11 linkc.252C>T p.Leu84Leu synonymous_variant Exon 4 of 7 1 NM_002872.5 ENSP00000249071.6 P15153

Frequencies

GnomAD3 genomes
AF:
0.0187
AC:
2844
AN:
152024
Hom.:
71
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0617
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00950
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000831
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00151
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.00510
AC:
804
AN:
157696
AF XY:
0.00420
show subpopulations
Gnomad AFR exome
AF:
0.0628
Gnomad AMR exome
AF:
0.00479
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000850
Gnomad NFE exome
AF:
0.00137
Gnomad OTH exome
AF:
0.00495
GnomAD4 exome
AF:
0.00269
AC:
3763
AN:
1400178
Hom.:
52
Cov.:
31
AF XY:
0.00248
AC XY:
1710
AN XY:
690708
show subpopulations
African (AFR)
AF:
0.0608
AC:
1923
AN:
31624
American (AMR)
AF:
0.00514
AC:
184
AN:
35806
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25184
East Asian (EAS)
AF:
0.0000559
AC:
2
AN:
35786
South Asian (SAS)
AF:
0.000378
AC:
30
AN:
79268
European-Finnish (FIN)
AF:
0.00122
AC:
60
AN:
49220
Middle Eastern (MID)
AF:
0.00614
AC:
35
AN:
5696
European-Non Finnish (NFE)
AF:
0.00114
AC:
1227
AN:
1079536
Other (OTH)
AF:
0.00520
AC:
302
AN:
58058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
229
458
686
915
1144
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0188
AC:
2861
AN:
152142
Hom.:
71
Cov.:
31
AF XY:
0.0188
AC XY:
1399
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0619
AC:
2567
AN:
41480
American (AMR)
AF:
0.00948
AC:
145
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000832
AC:
4
AN:
4810
European-Finnish (FIN)
AF:
0.00151
AC:
16
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00152
AC:
103
AN:
67986
Other (OTH)
AF:
0.0123
AC:
26
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
130
260
389
519
649
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00807
Hom.:
18
Bravo
AF:
0.0210
Asia WGS
AF:
0.00404
AC:
15
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 24, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:2
Nov 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Neutrophil immunodeficiency syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
4.8
DANN
Benign
0.78
PhyloP100
-2.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230919; hg19: chr22-37628008; API